TH - tyrosine hydroxylase Gene
Species: Oryctolagus cuniculus
Gene Type: protein coding
Gene ID: 100009362
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
tyrosine 3-monooxygenase |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(11)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-117287 | Deucravacitinib | Inhibitor | 99.93% | Unkown |
| HY-100754 | Ritlecitinib | Inhibitor | 99.80% | Yes |
| HY-N0394 | L-Cystine | 99.84% | Unkown | |
| HY-107916 | Thyrotropin | Inhibitor | / | Unkown |
| HY-B0976A | Fenoterol hydrobromide | Agonist | 99.97% | Unkown |
| HY-109520 | Glatiramer acetate | 98.0% | Unkown | |
| HY-B0976 | Fenoterol | Agonist | 99.08% | Unkown |
| HY-17002 | Suplatast (Tosilate) | Inhibitor | 99.67% | Unkown |
| HY-100754C | Ritlecitinib tosylate | Inhibitor | 99.65% | Yes |
| HY-100754A | Ritlecitinib malonate | Inhibitor | / | Unkown |
| HY-B0976AR | Fenoterol hydrobromide (Standard) | Agonist | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99025 | Lebrikizumab | Inhibitor | 99.90% | Unkown |
| HY-P99396 | Spesolimab | Inhibitor | 99.10% | Unkown |
| HY-P99256 | Tildrakizumab | Antagonist | 99.46% | Unkown |
Clinical Phase
Bioactive Molecules
(29)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-Y0344D | Sodium chloride, for cell culture | Activator | 99.9% | Phase 4 |
| HY-Y0344J | Sodium chloride, for molecular biology | 99.97% | Phase 4 | |
| HY-Y0344I | Sodium chloride, meets analytical specification of Ph. Eur. BP USP, ≤0.00002% Al | 99.99% | Phase 4 | |
| HY-124065 | ARRY-502 | Antagonist | / | Phase 4 |
| HY-Y0344H | Sodium chloride, United States Pharmacopeia (USP) Reference Standard | / | Phase 4 | |
| HY-B2132 | Tryptamine | 99.89% | Phase 3 | |
| HY-112137 | Trehalose-6,6'-dibehenate | Activator | 99.92% | Phase 3 |
| HY-10535 | Evofosfamide | Inducer | 98.0% | Phase 3 |
| HY-147410 | Ulefnersen | 99.22% | Phase 3 | |
| HY-147410A | Ulefnersen sodium | 98.47% | Phase 3 | |
| HY-13743 | Roquinimex | Inhibitor | 99.69% | Phase 3 |
| HY-160040A | Cobitolimod sodium | Agonist | / | Phase 3 |
| HY-13743R | Roquinimex (Standard) | Inhibitor | / | Phase 3 |
| HY-148074 | Zelnecirnon | Inhibitor | 99.71% | Phase 2 |
| HY-124573 | (R)-Odafosfamide | 98.52% | Phase 2 | |
| HY-16734A | Amiselimod hydrochloride | Agonist | 98.86% | Phase 2 |
| HY-15342 | Timapiprant | Antagonist | 98.12% | Phase 2 |
| HY-132828 | Odatroltide | Inhibitor | 97.39% | Phase 2 |
| HY-17632 | Tarloxotinib bromide | Inhibitor | 98.75% | Phase 2 |
| HY-15342A | Timapiprant sodium | Inhibitor | 99.61% | Phase 2 |
| HY-114141 | BI-671800 | Antagonist | 99.36% | Phase 2 |
| HY-118250 | GSK2245035 | 99.79% | Phase 2 | |
| HY-149040 | Odafosfamide | 99.06% | Phase 2 | |
| HY-103637A | Vimirogant hydrochloride | Inhibitor | 98.39% | Phase 2 |
| HY-16734 | Amiselimod | Modulator | / | Phase 2 |
| HY-12284 | NVP-QAV680 | Antagonist | / | Phase 2 |
| HY-103637 | Vimirogant | Inhibitor | / | Phase 2 |
| HY-137131 | DC-Chol hydrochloride | 99.95% | Phase 1 | |
| HY-159754 | HS201 | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P99757 | Nivatrotamab | Inhibitor | 99.00% | Phase 2 |
| HY-P991266 | SM-17 | Inhibitor | 96.98% | Phase 2 |
| HY-P991633 | TQC2938 | Inhibitor | / | Phase 2 |
| HY-P991257 | MK-1966 | Inhibitor | 96.17% | Phase 1 |
| HY-P99911 | Efizonerimod alfa | Agonist | 98.57% | Phase 1 |
| HY-P991258 | CNTO-5825 | 98.18% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(244)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-153808 | Complete Freund's adjuvant (CFA) | / | Unkown | |
| HY-15826 | SGC-CBP30 | Inhibitor | 99.83% | Unkown |
| HY-P1240 | MOG (35-55) mouse, rat | 99.73% | Unkown | |
| HY-126360 | Oxazolone | 98.0% | Unkown | |
| HY-146244 | Agatolimod | 98.84% | Unkown | |
| HY-150298 | Soquelitinib | Inhibitor | 99.98% | Unkown |
| HY-P10408 | Candidalysin | Activator | 99.81% | Unkown |
| HY-150741C | ODN 2216 sodium | Agonist | 98.57% | Unkown |
| HY-125801 | 3-Oxo-5β-cholanoic acid | Inhibitor | 99.37% | Unkown |
| HY-150741 | ODN 2216 | 98.57% | Unkown | |
| HY-101092 | QS-21-Api | Activator | 99.73% | Unkown |
| HY-116961 | TH1020 | 99.81% | Unkown | |
| HY-12776 | GSK805 | Inhibitor | 99.83% | Unkown |
| HY-147313 | TH10785 | Activator | 99.93% | Unkown |
| HY-P1240A | MOG (35-55) TFA | 99.68% | Unkown | |
| HY-113238A | Lithocholic acid 3-sulfate disodium | 99.93% | Unkown | |
| HY-138113 | Pyrrothiogatain | Inhibitor | 98.61% | Unkown |
| HY-143712 | Allolithocholic acid | 99.69% | Unkown | |
| HY-W009203 | L-Cystine dihydrochloride | 98.0% | Unkown | |
| HY-106224B | Orexin A (human, rat, mouse) acetate | Agonist | 99.53% | Unkown |
| HY-153808B | Complete Freund's adjuvant (CFA, 1 mg/ml) | / | Unkown | |
| HY-114360 | Taurohyodeoxycholic acid | Inhibitor | 99.73% | Unkown |
| HY-134771 | YM-341619 | Inhibitor | 98.01% | Unkown |
| HY-107413 | SR11237 | 99.99% | Unkown | |
| HY-155950 | TH9619 | 99.33% | Unkown | |
| HY-101392 | Harmane | Inhibitor | 99.91% | Unkown |
| HY-P2797A | Chitinase, Streptomyces griseus | / | Unkown | |
| HY-N2279 | Kurarinone | Activator | 99.47% | Unkown |
| HY-P1181A | Pam2CSK4 TFA | 99.46% | Unkown | |
| HY-N4084 | Thonningianin A | Inducer | 99.73% | Unkown |
| HY-123604 | TH1834 | 99.79% | Unkown | |
| HY-12814 | TH588 | Inhibitor | 99.20% | Unkown |
| HY-N0440 | Germacrone | 99.76% | Unkown | |
| HY-P3993A | (Gly14)-Humanin (human) acetate | Inhibitor | 99.86% | Unkown |
| HY-N6636 | Valencene | Inhibitor | 81.81% | Unkown |
| HY-111818 | TH34 | Inhibitor | 99.52% | Unkown |
| HY-161296 | TH6342 | Inhibitor | 99.15% | Unkown |
| HY-W012732 | Isoquinoline | Inhibitor | 99.58% | Unkown |
| HY-123604A | TH1834 dihydrochloride | 99.89% | Unkown | |
| HY-136065 | bpV(phen) | 98.0% | Unkown | |
| HY-W011220 | Ciglitazone | Agonist | 99.74% | Unkown |
| HY-125390 | SM-360320 | Agonist | 99.41% | Unkown |
| HY-N0885 | Telocinobufagin | 99.93% | Unkown | |
| HY-16965 | TH287 | Inhibitor | 98.99% | Unkown |
| HY-119684 | Maresin 2 | Inhibitor | 97.20% | Unkown |
| HY-122630 | TH-257 | Inhibitor | 98.36% | Unkown |
| HY-W009356 | L-Cystine hydrochloride | 98.0% | Unkown | |
| HY-125209 | TH5427 | Inhibitor | 99.92% | Unkown |
| HY-N0723 | Neomangiferin | 99.80% | Unkown | |
| HY-150167 | TH-Z93 | Inhibitor | 98.41% | Unkown |
| HY-122818 | BpV(phen) trihydrate | 98.0% | Unkown | |
| HY-150217 | CpG ODN 10101 | Agonist | 99.44% | Unkown |
| HY-P2797 | Chitinase, Serratia marcescens | / | Unkown | |
| HY-W016174 | Diphenyl sulfide | 99.71% | Unkown | |
| HY-108522 | PA452 | Antagonist | ≥99.0% | Unkown |
| HY-150168 | TH-Z145 | Inhibitor | 99.69% | Unkown |
| HY-N4087 | Platycodin D2 | Inducer | 99.84% | Unkown |
| HY-N6066 | Praeruptorin E | 99.83% | Unkown | |
| HY-B0927 | Hydrastine | Inhibitor | 99.57% | Unkown |
| HY-126328 | PKC-theta inhibitor 1 | Inhibitor | 99.45% | Unkown |
| HY-N0594 | Deacetylasperulosidic Acid | 99.44% | Unkown | |
| HY-W010520 | Methylisothiazolinone | 99.07% | Unkown | |
| HY-145848 | ERRγ agonist-1 | Agonist | 98.02% | Unkown |
| HY-159102 | PVP-037.2 | Agonist | 99.18% | Unkown |
| HY-135909 | TH1217 | Modulator | 99.20% | Unkown |
| HY-W677684 | Nurr1 agonist 2 | Agonist | 98.03% | Unkown |
| HY-114495 | Caerulomycin A | Inhibitor | 98.0% | Unkown |
| HY-N3138 | Ombuoside | 99.68% | Unkown | |
| HY-P10532 | Myelin basic protein, MBP (68-86) | 99.86% | Unkown | |
| HY-156466 | QL-1200186 | Inhibitor | 99.95% | Unkown |
| HY-146243 | TH-Z835 | 99.58% | Unkown | |
| HY-164278 | diABZI-V/C-Mal | 99.28% | Unkown | |
| HY-N10534 | Lewis X trisaccharide | Inhibitor | 99.91% | Unkown |
| HY-N7501 | Isoformononetin | Inhibitor | 99.47% | Unkown |
| HY-P10109 | G6PI 325-339 (human) | Activator | 95.00% | Unkown |
| HY-W018829 | 10-Undecenal | 98.36% | Unkown | |
| HY-120000 | MS402 | Inhibitor | 98.36% | Unkown |
| HY-151539 | TH470 | Inhibitor | 99.62% | Unkown |
| HY-173025 | Nurr1 agonist 12 | Agonist | 99.62% | Unkown |
| HY-126037 | (±)-ML 209 | Antagonist | 98.14% | Unkown |
| HY-139780 | JNJ-61803534 | Inhibitor | 99.84% | Unkown |
| HY-153663 | TH-Z827 | Inhibitor | 95.12% | Unkown |
| HY-N3388 | Licoisoflavone B | Inhibitor | 99.46% | Unkown |
| HY-N7512 | Asimilobine | 99.9% | Unkown | |
| HY-P3993 | (Gly14)-Humanin (human) | Inhibitor | 95.39% | Unkown |
| HY-101092B | QS-21-Xyl | 97.23% | Unkown | |
| HY-101392A | Harmane hydrochloride | Inhibitor | 99.88% | Unkown |
| HY-123468 | HA-1004 | Inhibitor | 99.04% | Unkown |
| HY-138115 | 7ß,27-Dihydroxycholesterol | Activator | 99.58% | Unkown |
| HY-145809 | FASN-IN-5 | Inhibitor | 99.98% | Unkown |
| HY-179537 | CKBA | Inhibitor | 98.97% | Unkown |
| HY-P1252 | Parathyroid Hormone (1-34), bovine | Agonist | 99.88% | Unkown |
| HY-W010243S | Methylisothiazolinone-d3 hydrochloride | 99.42% | Unkown | |
| HY-134113 | Z-Gly-Pro-Arg-pNA | 98.47% | Unkown | |
| HY-16668 | Tyrphostin A1 | Inhibitor | 98.96% | Unkown |
| HY-W783276 | 18:1(11-cis) PC | ≥99.0% | Unkown | |
| HY-110295 | SPL-334 | Inhibitor | 99.6% | Unkown |
| HY-120574 | TH1338 | Inhibitor | 98.77% | Unkown |
| HY-120785 | SR1555 | Antagonist | 99.69% | Unkown |
| HY-142998 | Vaxfectin | 99.94% | Unkown | |
| HY-155487 | JTE-151 | Inhibitor | 99.34% | Unkown |
| HY-158694A | TLR7 agonist 20 hydrochloride | Agonist | 99.86% | Unkown |
| HY-P2299A | Protein E7(43-62) TFA | 98.85% | Unkown | |
| HY-113238F | FITC-Lithocholic acid 3-sulfate | 90.01% | Unkown | |
| HY-167692 | JI069 | Inhibitor | 98.03% | Unkown |
| HY-N0394S5 | L-Cystine-13C6,15N2 | 98.4% | Unkown | |
| HY-164485 | INI-4001 | / | Unkown | |
| HY-159507 | Brezivaptan | Antagonist | 96.53% | Unkown |
| HY-135843 | TH-263 | Control | 99.0% | Unkown |
| HY-142938 | RORγt agonist 3 | Agonist | 98.12% | Unkown |
| HY-145491 | Resolvin D5 | Inhibitor | 98.3% | Unkown |
| HY-153662 | TH-Z816 | Inhibitor | 98.92% | Unkown |
| HY-155219 | TH9028 | / | Unkown | |
| HY-160040 | Cobitolimod | Agonist | 97.14% | Unkown |
| HY-174903 | ITK-IN-6 | Inhibitor | 99.02% | Unkown |
| HY-N10116A | Calamenene | / | Unkown | |
| HY-N9447 | Norbergenin | Inhibitor | 98.31% | Unkown |
| HY-P10463A | ssK36 TFA | Inhibitor | 99.34% | Unkown |
| HY-P1052A | Myelin Basic Protein(87-99) TFA | 99.23% | Unkown | |
| HY-P5333A | Aβ1-14-εK-KKK-MvF5 Th acetate | Inhibitor | 99.93% | Unkown |
| HY-W010243 | Methylisothiazolinone hydrochloride | 99.93% | Unkown | |
| HY-W777360 | Harman-13C2,15N | Inhibitor | 99.66% | Unkown |
| HY-127023 | Eicosapentaenoyl serotonin | Inhibitor | 99.0% | Unkown |
| HY-138143 | N-(p-Tosyl)-GPR-pNA acetate | 99.9% | Unkown | |
| HY-B0976AS | Fenoterol-d6 hydrobromide | Agonist | 98.02% | Unkown |
| HY-P5333 | Aβ1-14-εK-KKK-MvF5 Th | 98.05% | Unkown | |
| HY-117287A | Deucravacitinib (hydrochloride) | Inhibitor | / | Unkown |
| HY-128353 | ROR agonist-1 | Antagonist | / | Unkown |
| HY-125444 | TH251 | Inhibitor | / | Unkown |
| HY-126252 | A-9758 | Inhibitor | / | Unkown |
| HY-130243 | RORγt Inverse agonist 6 | Antagonist | 98.97% | Unkown |
| HY-142806 | RORγt inverse agonist 26 | / | Unkown | |
| HY-177835 | Liposomal Iron | / | Unkown | |
| HY-101871 | Trehalose 6-behenate | / | Unkown | |
| HY-107413G | SR11237 (GMP) | / | Unkown | |
| HY-112348 | HA-1004 hydrochloride | Inhibitor | / | Unkown |
| HY-116890 | CRTh2 antagonist 4 | Antagonist | / | Unkown |
| HY-118250A | GSK2245035 maleate | / | Unkown | |
| HY-118428 | Fluenetil | / | Unkown | |
| HY-120225 | NJK14047 | Inhibitor | / | Unkown |
| HY-120785A | SR1555 hydrochloride | Antagonist | / | Unkown |
| HY-122349 | Lotrifen | / | Unkown | |
| HY-123568 | PBI-1393 | Inhibitor | / | Unkown |
| HY-125209A | TH5427 hydrochloride | / | Unkown | |
| HY-125693 | L685818 | Inhibitor | / | Unkown |
| HY-125801S | 3-Oxo-5β-cholanoic acid-d4 | / | Unkown | |
| HY-132851 | Corixetan | / | Unkown | |
| HY-134192 | TH301 | / | Unkown | |
| HY-135773 | CRTh2 antagonist 3 | / | Unkown | |
| HY-137292 | PTB7-Th | / | Unkown | |
| HY-139193 | TH1760 | Inhibitor | / | Unkown |
| HY-142703 | RORγt inverse agonist 28 | Inhibitor | / | Unkown |
| HY-142937 | RORγt agonist 2 | Agonist | / | Unkown |
| HY-143712R | Allolithocholic acid (Standard) | / | Unkown | |
| HY-143712S1 | Allolithocholic Acid-d4 | / | Unkown | |
| HY-143885 | JAK1/TYK2-IN-3 | Inhibitor | / | Unkown |
| HY-145577 | Lafadofensine | Inhibitor | / | Unkown |
| HY-149029 | TH-6 | 95.00% | Unkown | |
| HY-155505 | AHR agonist 4 | Agonist | / | Unkown |
| HY-155680 | BET BD2-IN-1 | Inhibitor | / | Unkown |
| HY-157020 | UniPR1449 | Antagonist | / | Unkown |
| HY-158694 | TLR7 agonist 20 | Agonist | / | Unkown |
| HY-161255 | 3,4-DAA | Inhibitor | / | Unkown |
| HY-162490 | TF-S14 | Inhibitor | / | Unkown |
| HY-162727 | GCS-12 | / | Unkown | |
| HY-163704 | KRN7000 analog 1 | / | Unkown | |
| HY-163801 | Nurr1 agonist 9 | Agonist | / | Unkown |
| HY-168207 | TH023 | Inhibitor | / | Unkown |
| HY-168347 | TH152 | Ligand | / | Unkown |
| HY-172692 | DSPE-PEG1000-TH | / | Unkown | |
| HY-172693 | DSPE-PEG2000-TH | / | Unkown | |
| HY-172694 | DSPE-PEG5000-TH | / | Unkown | |
| HY-175365 | GCS-12–6 | Ligand | / | Unkown |
| HY-175876 | ADAM17-IN-1 | Inhibitor | / | Unkown |
| HY-176262 | TH10184 | Ligand | / | Unkown |
| HY-176263 | TH10184-octanedioic acid | / | Unkown | |
| HY-176273 | RORγt inverse agonist 35 | Agonist | / | Unkown |
| HY-176535 | KB-0118 | Inhibitor | / | Unkown |
| HY-177277 | HM5023507 | Inhibitor | / | Unkown |
| HY-178240 | rel-(1S,2R)-Dihydro bupropion | Inhibitor | / | Unkown |
| HY-178721 | Lithocholic amide-C2-N(didecane) | Inhibitor | / | Unkown |
| HY-178966 | STING agonist-48 | Agonist | / | Unkown |
| HY-181739 | GCB-27a | Activator | / | Unkown |
| HY-181740 | GCB-27b | Activator | / | Unkown |
| HY-184214 | Antileishmanial agent-44 | / | Unkown | |
| HY-184273 | TH-407a | Inhibitor | / | Unkown |
| HY-186084 | ACSL5-IN-4 | / | Unkown | |
| HY-D3366 | Th-TMR-S-Halo | / | Unkown | |
| HY-D3367 | Th-TMR-S-SNAP | / | Unkown | |
| HY-N15846 | VSA 1 | / | Unkown | |
| HY-N16465 | Cinnamtannin D1 | Inhibitor | / | Unkown |
| HY-N18080 | Parthenin | Inhibitor | / | Unkown |
| HY-N18279 | Bulbocapnine | Antagonist | / | Unkown |
| HY-N6636R | Valencene (Standard) | Inhibitor | / | Unkown |
| HY-N7501S | Isoformononetin-d3 | 98.64% | Unkown | |
| HY-N7869 | Celangulin VII | / | Unkown | |
| HY-P10109A | G6PI 325-339 (human) hydrochloride | Activator | / | Unkown |
| HY-P10982 | SjDX5-53 | Inducer | / | Unkown |
| HY-P10984 | FNIII14 | Inhibitor | / | Unkown |
| HY-P1181 | Pam2CSK4 | / | Unkown | |
| HY-P11838 | DOTA-TH10 | / | Unkown | |
| HY-P1252A | Parathyroid Hormone (1-34), bovine TFA | Agonist | / | Unkown |
| HY-P2299 | Protein E7(43-62) | / | Unkown | |
| HY-P2797B | Chitinase | / | Unkown | |
| HY-P2797C | Chitinase,Trichoderma viride | / | Unkown | |
| HY-P4389 | (Asp28)-Glucagon (1-29) (human, rat, porcine) | Activator | / | Unkown |
| HY-P4790 | Acetyl-Exenatide | Inhibitor | / | Unkown |
| HY-RS14467 | TH Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W010520R | Methylisothiazolinone (Standard) | / | Unkown | |
| HY-W012732S2 | Isoquinoline-15N | / | Unkown | |
| HY-W683409 | Dimorpholamine | / | Unkown | |
| HY-W700834 | Harman-d3 | / | Unkown | |
| HY-W761985 | Furathiocarb | / | Unkown | |
| HY-W772717 | L-Cystine disodium monohydrate | / | Unkown | |
| HY-W795993 | TJU103 | Inhibitor | / | Unkown |
| HY-107413R | SR11237 (Standard) | / | Unkown | |
| HY-11054 | TH-237A | 98.55% | Unkown | |
| HY-112863 | RORγt inhibitor 3 | Inhibitor | / | Unkown |
| HY-12814A | TH588 hydrochloride | Inhibitor | / | Unkown |
| HY-148014 | TH7299 | / | Unkown | |
| HY-157675 | 1,2-Dinervonoyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-164454 | AJI-100 | Inhibitor | / | Unkown |
| HY-164455 | AJI-214 | Inhibitor | / | Unkown |
| HY-16965A | TH287 hydrochloride | Inhibitor | / | Unkown |
| HY-174603 | Human IL4R mRNA | / | Unkown | |
| HY-174607 | Human IL33 mRNA | / | Unkown | |
| HY-174639 | Human IL13 mRNA | / | Unkown | |
| HY-174641 | Human IL12B mRNA | / | Unkown | |
| HY-174642 | Human IL12A mRNA | / | Unkown | |
| HY-175301 | TH16 | / | Unkown | |
| HY-175376 | QPyN16Th | Inhibitor | / | Unkown |
| HY-177300 | TLR7/8 agonist 13 | / | Unkown | |
| HY-183046 | PAICS-IN-1 | Activator | / | Unkown |
| HY-183448 | ETMTC | / | Unkown | |
| HY-N0594R | Deacetylasperulosidic Acid (Standard) | / | Unkown | |
| HY-N0976 | 1,11b-Dihydro-11b-hydroxymedicarpin | Activator | / | Unkown |
| HY-N3548 | Catalpalactone | Inhibitor | / | Unkown |
| HY-P10463 | ssK36 | Inhibitor | / | Unkown |
| HY-RS16660 | Th Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23095 | Th Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W018829R | 10-Undecenal (Standard) | / | Unkown | |
| HY-W130878 | 4-Octylphenol | Activator | / | Unkown |
| HY-W745349 | rel-(1S,2R)-Dihydro bupropion-d9 hydrochloride | Inhibitor | / | Unkown |
| HY-W777138 | rel-(1S,2R)-Dihydro bupropion-d9 | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(14)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990121 | Anti-Mouse IL-4 Antibody (11B11) | Inhibitor | 97.67% | Unkown |
| HY-P99301 | Lokivetmab | Inhibitor | ≥99.0% | Unkown |
| HY-P990219 | Anti-Mouse IL-2 Antibody (JES6-1A12) | Inhibitor | 99% | Unkown |
| HY-P990145 | Anti-Mouse VISTA Antibody (13F3) | Inhibitor | ≥95.0% | Unkown |
| HY-P990208 | Anti-Mouse IL-9 Antibody (9C1) | Inhibitor | 95.00% | Unkown |
| HY-P990124 | Anti-Mouse GITR Antibody (DTA-1) | 98.47% | Unkown | |
| HY-P990796 | Anti-Mouse IL-2 Antibody (S4B6-1) | Inhibitor | 96.97% | Unkown |
| HY-P992132 | Solaprubart | Inhibitor | 99.59% | Unkown |
| HY-P990177 | Anti-Mouse Notch4 Antibody (HMN4-14) | Inhibitor | / | Unkown |
| HY-P990206 | Anti-Mouse Jagged 2 Antibody (HMJ2-1) | Inhibitor | / | Unkown |
| HY-P991274 | BMS-986010 | Inhibitor | / | Unkown |
| HY-P991380 | TXB4 | Inhibitor | / | Unkown |
| HY-P991467 | RG-7258 | Inhibitor | / | Unkown |
| HY-P990252 | Anti-Mouse Delta-like protein 4/DLL4 Antibody (HMD4-2) | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service